Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Hong Kong's economy recorded a 3.8% year-on-year increase in the fourth quarter, marking a 12th straight quarter of growth. For 2025 overall, real GDP rose 3.5%, surpassing the government's 3.2% projection, supported by stronger trade flows, rising inbound tourism and activity in financial services.
European stock indexes advanced on Friday, supported by broadly positive corporate earnings and encouraging economic readings in the euro area. Gains were tempered by persistent geopolitical strains and developments in U.S. policy that lifted the dollar and pressured commodity prices. Key companies reporting results included Adidas, Swatch, Caixaba…
MEET48 reported the destruction of 8,698,560 IDOL tokens on January 30, 2026, representing 30% of voting income from its second 'MEET48 Best7' event. The votes generated 28,995,200 IDOL tokens, equal to 0.604% of total supply, while the burned portion equals 0.181% of supply. The project also disclosed user activity metrics and a product roadmap th…
TXO Partners (TXO) trades near $12 with a 16%+ distribution yield, a low debt-to-equity ratio of 0.37 and an EV/EBITDA of ~10.6. This trade idea targets a mid-term re-rate into the low-teens/teens driven by yield-hungry buyers and improving operational headlines. Entry $11.98, stop $10.30, target $15.00, horizon: mid term (45 trading days).
National data released on Friday show the euro zone's largest economies delivered modest but consistent expansion in the final quarter of 2025. Stronger household spending and business investment helped compensate for sluggish exports and lingering uncertainty from U.S. trade policy. Early 2026 indicators point to continued resilience, while struct…
Safilo Group reported a 12.4% rise in adjusted EBITDA for Q4 2025 to €19.8 million, beating analyst expectations, while sales fell 4.6% to €225 million. Improved gross margins and cost management helped offset tariff pressures, and the company cut net debt materially over the year even after spending on an acquisition stake and share buybacks.
Scatec posted fourth-quarter consolidated results that fell short of analyst expectations, with revenue and EBITDA declining year-on-year and quarter-on-quarter. On a proportionate basis, power production and Power Production EBITDA were roughly in line with forecasts, and Development & Construction delivered materially stronger EBITDA than anticip…
Macquarie upgraded TAL International (NYSE:TAL) from Neutral to Outperform and lifted its price target to $18.00 from $13.10, implying roughly 42% upside from a $12.70 share price. The upgrade follows year-over-year gains across TAL’s learning services and learning devices segments, a reversal to non-GAAP operating profitability in Q3 FY2025, and s…
StarragTornos reported preliminary 2025 results showing a 10.5% decline in net sales to CHF442.1 million, missing analyst expectations. Order intake held near prior-year levels at CHF472.8 million, producing a book-to-bill of 1.07x. A fourth-quarter uplift in aerospace orders increased the year-end backlog to CHF336.4 million. Management warned tha…
InfuSystem (INFU) is a cash-generative provider of home infusion and device services trading at about $8.00. Modest growth, improving margins and a sensible balance sheet make it a reasonable mid-term long trade if regulatory clarity or reimbursement tailwinds materialize. Entry $7.95, stop $7.20, target $10.50 over ~45 trading days.
Morgan Stanley raised Hexcel Corp. (HXL) to Equalweight from Underweight and lifted its price target to $90 from $67 after the company reported better-than-expected fourth-quarter 2025 results and signaled improving operating margins tied to rising commercial OEM production. The bank forecasts stronger EPS growth for Hexcel versus peers but notes t…
UBS downgraded Antofagasta from Buy to Neutral while increasing its price target to GBP42.00 from GBP35.00, pointing to the stock's substantial outperformance and stretched valuation. InvestingPro data shows the shares trading at $49.43 and flags elevated multiples versus historical norms, amid strong shareholder returns and sector-wide momentum dr…
DSM-Firmenich is reportedly close to agreeing a sale of its Animal Nutrition and Health division to CVC Capital Partners in a transaction that could be announced within days and valued at roughly €2.2 billion ($2.6 billion). The company is expected to retain a stake under the proposed terms, though negotiations remain ongoing and previous discussio…
UBS cut its recommendation on China Mobile from Buy to Neutral and trimmed the price target to RMB81.00 from RMB100.00, arguing the stock has limited upside from current levels. The broker points to a lack of re-rating catalysts, competitive pressure from internet hyperscalers in cloud and AI, and modest earnings growth expectations even as the com…
Indonesia's benchmark index ended the trading day higher, driven by advances in Financials, Agriculture and Basic Industry. The IDX Composite rose 0.88% at the close in Jakarta. Several small-cap names posted outsized gains, while a handful of stocks recorded steep declines. Commodity prices, including crude oil and gold, retreated and the rupiah w…
Jefferies has launched coverage of Engene Holdings Inc. (ENGN) with a Buy rating and a $28 price target, implying roughly 173% upside from the stock's current level of $10.27. The firm highlights Engene's ongoing pivotal study in high-risk non-muscle invasive bladder cancer (HR-NMIBC), a key data update expected in the second half of 2026, and favo…
European equities advanced modestly on Friday as investors balanced upbeat corporate results against persistent geopolitical and trade concerns. The STOXX 600 rose 0.1% by 0804 GMT and was poised for a 2.6% gain for January if current levels held, marking a seventh consecutive monthly increase - the longest run since 2021. Market participants noted…
Citizens has cut its rating on SAP from Market Outperform to Market Perform following a set of fourth-quarter results that mixed an above-consensus non-IFRS EPS and operating profit with revenue and cloud metrics that fell short of expectations. The stock has seen significant recent volatility, trading near $200 and sliding sharply in the week afte…
China's central government recorded a 1.7% fall in fiscal revenue in 2025, the first contraction since 2020, as a prolonged property downturn and fragile domestic demand reduced receipts. Total fiscal revenue reached 21.6 trillion yuan, while public spending rose 1% to 28.7 trillion yuan. Tax receipts rose modestly, but non-tax income and land-sale…
Bernstein's recent analysis singles out ten European medical technology companies with differentiated pathways to stronger performance in 2026. The list spans dental specialists, biomanufacturing suppliers, diagnostics and hearing-aid leaders. Key drivers cited include end-market recoveries, product cycles, margin mix improvements, capacity moves a…
Avio SpA updated its full-year 2025 outlook, citing robust commercial momentum in the fourth quarter and quicker-than-expected contract execution. The company raised its projected order backlog and group revenue ranges, reported a net cash position approaching €600 million, and left profit and EBITDA guidance intact.
Drax has entered a 10-year tolling agreement with West Burton C Limited, owned by Fidra Energy, for 250MW (500MWh) of battery energy storage capacity. Fidra will finance construction, provide maintenance and guarantee availability with no upfront capital outlay from Drax. Under the contract Drax will pay an annual tolling fee indexed to UK CPI, gai…
Tetragon Financial Group reported a diluted net asset value (NAV) per share of $41.88 as of December 31, 2025, a 0.1% increase for the month. For the full year 2025 the investment company recorded a NAV total return of 19.6%. Under the surface, portfolio-level write-downs to LCM and Ripple were largely counterbalanced by a modest write-up to Equiti…
Recordati has entered a strategic collaboration with Moderna to develop and commercialize mRNA-3927 for propionic acidemia (PA). The deal includes a $50 million upfront payment, up to $110 million in near-term milestone payments, and tiered royalties, while pivotal data are expected by the end of 2026. Recordati says material EBITDA effects are not…
Stelrad Group reported a rise in adjusted operating profit for the year ended December 31, 2025, underpinned by margin management, cost reductions and a stronger mix, even as volumes fell 4% year-on-year. Revenue was about £280 million, adjusted operating profit rose to approximately £32.5 million and net debt before lease liabilities fell to £51.2…
